Contraceptive Clinical Trials Network - Female Sites08/01/2020 - 07/31/2027 (PI)
NIH-NICHD
BAY 86-5028/1864910/02/2017 - 12/31/2025 (PI)
Bayer Healthcare Pharmaceuticals, Inc.
Phase 3 double-blind placebo-controlled efficacy trial of EVO100 vaginal gel for the prevention of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection (EVOGUARD)02/11/2021 - 02/10/2024 (PI)
Evofem, Inc.
MK8415-060 Nexplanon Extension: A Phase 3, Open-label, Multi12/02/2020 - 12/01/2023 (PI)
Merck
Partners in Contraceptive Choice and Knowledge10/10/2018 - 09/30/2023 (PI)
Exec Office of Health & Human Svcs
Birth Control to Improve Birth Spacing07/15/2021 - 06/30/2023 (PI)
Brigham and Womens Hospital National Institute o1R21HD103977-01A1
Development and ex vivo evaluation of a novel, non-hormonal07/01/2021 - 06/30/2023 (PI)
Massachusetts Life Sciences Center
Pharmacokinetic/Pharmacodynamic Evaluation of Levonorgestrel Butanoate for Female Contraception09/28/2018 - 09/30/2022 (PI)
NIH-NICHD
Ryan Residency Training and Fellowship in Family Planning10/01/2017 - 07/31/2022 (PI)
University of California, San Francisco Susan Thompson Buffe
Clinical Evaluation of Long-Acting Reversible Contraceptives09/25/2015 - 07/31/2022 (PI)
NIH-NICHD
Showing 10 of 17 results.
Show All Results
MDPH Sexual and Reproductive Health Training Center
01/01/2022 - 06/30/2022 (PI)
John Snow, Inc. Massachusetts Dept.
Fellowship in Family Planning – General and Special Requirem
07/01/2019 - 06/30/2022 (PI)
Susan Thompson Buffett Foundation
Contraceptive Clinical Trials Network - Female Sites : Core Function Activities
06/26/2013 - 06/30/2021 (PI)
NIH-NICHD
Freedom/Estetra
11/30/2016 - 11/30/2019 (PI)
Estetra SPRL
The IDEAS study
10/01/2017 - 09/30/2019 (PI)
Society of Family Planning
MK-8342B
06/20/2016 - 02/28/2019 (PI)
Merck
Family Planning Fellowship Graduate Evaluation
05/01/2017 - 06/30/2018 (PI)
Susan Thompson Buffett Foundation